Corrigendum: The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

• Ningning Yan,
• Sanxing Guo,
• Siyuan Huang,
• Huixian Zhang,
• Xingya Li

Affiliations

Ningning Yan

Sanxing Guo

Siyuan Huang

Huixian Zhang

Xingya Li